MXEBX
Price
$18.96
Change
-$0.14 (-0.73%)
Updated
Jul 13 closing price
Net Assets
817.37M
VSMPX
Price
$337.67
Change
-$2.70 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

MXEBX vs VSMPX

MXEBX vs VSMPX Comparison Chart in %
View a ticker or compare two or three
VS
MXEBX vs. VSMPX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MXEBX is a Buy and VSMPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 2.3T vs. MXEBX (817M). VSMPX pays higher dividends than MXEBX: VSMPX (1.06) vs MXEBX (0.94). MXEBX was incepted earlier than VSMPX: MXEBX (8 years) vs VSMPX (11 years). MXEBX (0.68) is less costly to investors than VSMPX (0.02). MXEBX is a more actively managed with annual turnover of: 28.00 vs. VSMPX (3.00). MXEBX has a lower initial minimum investment than VSMPX: MXEBX (0) vs VSMPX (100000000). VSMPX annual gain was more profitable for investors over the last year : 21.48 vs. MXEBX (17.23). VSMPX return over 5 years is better than : 66.52 vs. MXEBX (39.55).
MXEBXVSMPXMXEBX / VSMPX
Total Expense Ratio0.550.022,750%
Annual Report Gross Expense Ratio0.680.023,400%
Fund Existence8 years11 years-
Gain YTD12.51711.206112%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets817M2.3T0%
Annual Yield % from dividends0.941.0689%
Returns for 1 year17.2321.4880%
Returns for 3 years50.8467.0376%
Returns for 5 years39.5566.5259%
Returns for 10 yearsN/A239.43-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGSNX21.35N/A
N/A
Vanguard Real Estate Index Institutional
PCAOX91.03N/A
N/A
Principal Capital Appreciation R3
GARIX23.88N/A
N/A
Gotham Absolute Return Institutional
RLAIX24.27N/A
N/A
T. Rowe Price Latin America I
MCYCX15.72-0.49
-3.02%
NYLI Candriam Emerging Markets Eq Cl C